Evan Geller

Evan Geller, PhD, is a trained Genomicist and Neurodevelopmental Biologist with expertise in high-throughput CRISPR screening, single-cell sequencing, and animal modeling. They obtained their PhD in Genomics from Yale University and completed postdoctoral training at the New York Genome Center. Previously, Evan worked as a Research Specialist at the University of Pennsylvania, focusing on identifying new autism risk genes through whole-exome sequencing. Currently, they serve as a Senior Scientist at Immunai, leading projects in gene editing and genomic technology development aimed at advancing immunotherapy.